home / stock / xph / xph news


XPH News and Press, SPDR S&P Pharmaceuticals From 01/11/23

Stock Information

Company Name: SPDR S&P Pharmaceuticals
Stock Symbol: XPH
Market: NYSE

Menu

XPH XPH Quote XPH Short XPH News XPH Articles XPH Message Board
Get XPH Alerts

News, Short Squeeze, Breakout and More Instantly...

XPH - Can Health Care Stocks Outperform Again In 2023?

Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...

XPH - Eli Lilly: Right Industry, Wrong Price

Summary Eli Lilly currently has a forward P/E of over 45x. This high valuation is much higher than the sector average. A pair trade between XPH and LLY is proposed. Introduction I give Eli Lilly ( LLY ) a sell rating. While I am bullish on the pharmaceutical space due ...

XPH - Investment Strategy Monthly Insights, December 2022

Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...

XPH - Global Sector Data Reveal Broadening Slowdown With Financial Services Leading The Downturn

Summary Global business conditions worsened in the penultimate month of the year according to the JPMorgan Global Composite PMI, compiled by S&P Global. New order expansions were seen in merely three of the 21 sectors tracked by the global PMI - software & services, pharmaceutic...

XPH - Global X House Views - December

Summary Expectations surrounding central bank policy, China’s gradual reopening and a lower US dollar are key to investor sentiment in the final stretch of 2022. Central banks have increased interest rates at the fastest rate on record, and there are signs that higher yields are ...

XPH - Stock Surge To Meet Recession Reality

Summary Surging stocks show markets believe hopes of a soft landing by the Fed to be true. We disagree and stay underweight developed market (DM) stocks. U.S. stocks jumped and bond yields plunged after October CPI rose less than the market expected. But sticky core inflation keep...

XPH - U.S. Midterm Elections: Win, Lose Or Draw For Markets?

Summary U.S. midterm elections: Win, lose or draw for markets? What sectors may benefit from a divided government. Will equity markets get the post midterm election bump? For further details see: U.S. Midterm Elections: Win, Lose Or Draw For Markets? ...

XPH - XPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically Unattractive

Summary XPH invests in U.S. pharmaceuticals stocks. The fund is concentrated in 44 holdings. It is difficult to value the fund, as earnings are less transparent as compared to most other sectors, which I would argue deserves a higher average equity risk premium. On balance...

XPH - Finding Pockets Of Strength In A Down Market

Summary Why the declines in tech on the S&P 500 may be hiding strength in other sectors from investors. The energy sector may still provide opportunities for investors. Insurers are not suffering the same challenges as other financials in the current high-rate environment....

XPH - The 1-Minute Market Report November 10, 2022

Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...

Previous 10 Next 10